Peter Ellmark

Peter Ellmark

Company: Alligator Biosciences

Job title: CSO


Learning from CD40 Candidates in Phase II to Inform Back-Translation and Optimize Novel Dendritic & Macrophage-Targeting Therapy 1:00 pm

• Sharing clinical learnings from CD40-targeting antibody therapy in pancreatic cancer • Discussing the design and outline of studies to address dendritic cells and macrophages • Translating clinical learnings to preclinical CD40 bispecific therapy to drive stronger dendritic cell activation and cross presentationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.